Tepadina
What Tepadina is used for
TEPADINA is indicated, in combination with other chemotherapy medicinal products:- with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;- when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.
Approved use, as published by the European Medicines Agency.
Key facts
- Brand
- Tepadina
- Active substance
- thiotepa
- Disease area
- Hematopoietic Stem Cell Transplantation
- Medicine group
- Antineoplastic agents
- ATC code
- L01AC01
- Authorised in the EU since
- 2010
Official information
In the USA
Same active substance: Tepadina
In India
- Thiotepa: 4 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tepadina used for?
TEPADINA is indicated, in combination with other chemotherapy medicinal products:- with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;- when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.
What is the active substance in Tepadina?
Tepadina contains thiotepa.
Who makes Tepadina?
The EU marketing authorisation holder is .
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU